Skip to main content

Table 6 Serious adverse events (safety population)

From: Safety of three different product doses in autologous chondrocyte implantation: results of a prospective, randomised, controlled trial

Dose group

Adverse event

During year after implantation

Severity

Relationship to treatment

Outcome

Low

Convulsion

1st

Moderate

None

Resolved

Arthralgia

1st

Moderate

None

Resolved

Meniscus lesion

2nd

Severe

None

Resolved

Chondropathy

3rd

Moderate

Unlikely

Resolved

Arthralgia

3rd

Moderate

Probable

Resolved

Uterine cyst

3rd

Moderate

None

Resolved

Medium

Syncope

2nd

Severe

None

Resolved

Chondropathy

3rd

Moderate

None

Not resolved

High

Umbilical hernia

2nd

Mild

None

Resolved

Chondropathya

2nd

Severe

Probable

Resolved

Arthralgia

3rd

Moderate

None

Resolved

  1. aTwo episodes in the same patient